Efficacy and safety of Huxin formula in patients after CABG: a multicenter, double-blind, randomized clinical trial.

CONCLUSION: Huxin Formula may improve cardiac function of patients with 3 coronary vessel lesions and relieve symptoms of patients with cardiac function class II but failed to show superiority in primary outcomes. PMID: 25592946 [PubMed - in process]
Source: Forschende Komplementarmedizin - Category: Complementary Medicine Tags: Forsch Komplementmed Source Type: research